Palatin Technologies (PTN) Interest & Investment Income (2010 - 2026)
Palatin Technologies' (PTN) quarterly Interest & Investment Income came in at $149275.0 in Q1 2026, up 374.61% YoY from $31452.0 in Q1 2025, and up 129.0% on a QoQ basis from $65185.0 in Q4 2025.
Palatin Technologies (PTN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 16 years of Interest & Investment Income data on file, last reported at $149275.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 374.61% year-over-year to $149275.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $261536.0 (up 7.63% YoY) and the FY2025 annual result came in at $167665.0, down 55.51% from the prior year.
- Interest & Investment Income rose to $149275.0 in Q1 2026, from $65185.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $234044.0 in Q1 2023 to a low of $1127.0 in Q1 2022.
- A 5-year average of $88024.8 and a median of $71630.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 20666.99% — and 2025, when it slumped 77.42%.
- Tracing PTN's Interest & Investment Income over 5 years: stood at $186473.0 in 2022, then plunged by 66.74% to $62026.0 in 2023, then tumbled by 53.17% to $29044.0 in 2024, then soared by 124.44% to $65185.0 in 2025, then surged by 129.0% to $149275.0 in 2026.
- The last three Interest & Investment Income figures came in at $149275.0 (Q1 2026), $65185.0 (Q4 2025), and $18483.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | 149,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149,275.00 |
| Dec 31, 2025 | 65,185.00 |
| Sep 30, 2025 | 18,483.00 |
| Jun 30, 2025 | 28,593.00 |
| Mar 31, 2025 | 31,452.00 |
| Dec 31, 2024 | 29,044.00 |
| Sep 30, 2024 | 78,576.00 |
| Jun 30, 2024 | 103,914.00 |
| Mar 31, 2024 | 139,273.00 |
| Dec 31, 2023 | 62,026.00 |
| Sep 30, 2023 | 71,630.00 |
| Jun 30, 2023 | 182,975.00 |
| Mar 31, 2023 | 234,044.00 |
| Dec 31, 2022 | 186,473.00 |
| Sep 30, 2022 | 88,489.00 |
| Jun 30, 2022 | 25,863.00 |
| Mar 31, 2022 | 1,127.00 |
| Dec 31, 2021 | 1,563.00 |
| Sep 30, 2021 | 1,410.00 |
| Jun 30, 2021 | 3,803.00 |